受强制性开放获取政策约束的文章 - MARGHERITA Brindisi了解详情
无法在其他位置公开访问的文章：21 篇
Old but gold: tracking the new guise of histone deacetylase 6 (HDAC6) enzyme as a biomarker and therapeutic target in rare diseases
M Brindisi, AP Saraswati, S Brogi, S Gemma, S Butini, G Campiani
Journal of medicinal chemistry 63 (1), 23-39, 2019
强制性开放获取政策： Department of Biotechnology, India, Government of Italy
Polypharmacology of dopamine receptor ligands
S Butini, K Nikolic, S Kassel, H Brückmann, S Filipic, D Agbaba, S Gemma, ...
Progress in neurobiology 142, 68-103, 2016
强制性开放获取政策： German Research Foundation, European Commission
Autophagy modulators for the treatment of oral and esophageal squamous cell carcinomas
T Khan, N Relitti, M Brindisi, S Magnano, D Zisterer, S Gemma, S Butini, ...
Medicinal research reviews 40 (3), 1002-1060, 2020
强制性开放获取政策： European Commission
Mimicking the intramolecular hydrogen bond: synthesis, biological evaluation, and molecular modeling of benzoxazines and quinazolines as potential antimalarial agents
S Gemma, C Camodeca, M Brindisi, S Brogi, G Kukreja, S Kunjir, ...
Journal of medicinal chemistry 55 (23), 10387-10404, 2012
强制性开放获取政策： National Health and Medical Research Council, Australia
Telomerase-based cancer therapeutics: a review on their clinical trials
N Relitti, AP Saraswati, S Federico, T Khan, M Brindisi, D Zisterer, S Brogi, ...
Current Topics in Medicinal Chemistry 20 (6), 433-457, 2020
强制性开放获取政策： European Commission
Rational design of the first difluorostatone-based PfSUB1 inhibitors
S Giovani, M Penzo, S Brogi, M Brindisi, S Gemma, E Novellino, L Savini, ...
Bioorganic & medicinal chemistry letters 24 (15), 3582-3586, 2014
强制性开放获取政策： UK Medical Research Council, Government of Italy
Flow synthesis approaches to privileged scaffolds–recent routes reviewed for green and sustainable aspects
AI Alfano, M Brindisi, H Lange
Green Chemistry 23 (6), 2233-2292, 2021
强制性开放获取政策： Government of Italy
Raising the bar in anticancer therapy: Recent advances in, and perspectives on, telomerase inhibitors
AP Saraswati, N Relitti, M Brindisi, S Gemma, D Zisterer, S Butini, ...
Drug discovery today 24 (7), 1370-1388, 2019
强制性开放获取政策： European Commission
Novel quinolone-based potent and selective HDAC6 inhibitors: synthesis, molecular modelling studies and biological investigation
N Relitti, AP Saraswati, G Chemi, M Brindisi, S Brogi, D Herp, ...
European Journal of Medicinal Chemistry, 112998, 2020
强制性开放获取政策： European Commission, Government of Italy
Screening and Phenotypical Characterization of Schistosoma mansoni Histone Deacetylase 8 (SmHDAC8) Inhibitors as Multistage Antischistosomal Agents
F Saccoccia, M Brindisi, R Gimmelli, N Relitti, A Guidi, AP Saraswati, ...
ACS Infectious Diseases 6 (1), 100-113, 2019
强制性开放获取政策： German Research Foundation, European Commission, Government of Italy
Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies
M Brindisi, C Cavella, S Brogi, A Nebbioso, J Senger, S Maramai, A Ciotta, ...
Future medicinal chemistry 8 (13), 1573-1587, 2016
强制性开放获取政策： German Research Foundation, European Commission, Government of Italy
A stereoselective approach to peptidomimetic BACE1 inhibitors
S Butini, E Gabellieri, M Brindisi, S Giovani, S Maramai, G Kshirsagar, ...
European journal of medicinal chemistry 70, 233-247, 2013
强制性开放获取政策： Government of Italy
From (+)-epigallocatechin gallate to a simplified synthetic analogue as a cytoadherence inhibitor for P. falciparum
S Gemma, S Brogi, PR Patil, S Giovani, S Lamponi, A Cappelli, ...
RSC Advances 4 (9), 4769-4781, 2014
强制性开放获取政策： Government of Italy
The novel pyrrolo-1, 5-benzoxazepine, PBOX-21, potentiates the apoptotic efficacy of STI571 (imatinib mesylate) in human chronic myeloid leukaemia cells
SA Bright, LM Greene, TF Greene, G Campiani, S Butini, M Brindisi, ...
Biochemical pharmacology 77 (3), 310-321, 2009
强制性开放获取政策： Science Foundation Ireland
Dealing with schistosomiasis: Current drug discovery strategies
S Gemma, S Federico, S Brogi, M Brindisi, S Butini, G Campiani
Annual Reports in Medicinal Chemistry 53, 107-138, 2019
强制性开放获取政策： Government of Italy
Unconventional Knoevenagel-type indoles: Synthesis and cell-based studies for the identification of pro-apoptotic agents
A Spallarossa, C Caneva, M Caviglia, S Alfei, S Butini, G Campiani, ...
European journal of medicinal chemistry 102, 648-660, 2015
强制性开放获取政策： Government of Italy
A light in the dark: state of the art and perspectives in optogenetics and optopharmacology for restoring vision
G Chemi, M Brindisi, S Brogi, N Relitti, S Butini, S Gemma, G Campiani
Future medicinal chemistry 11 (5), 463-487, 2019
强制性开放获取政策： Government of Italy
Efficacy of selective histone deacetylase 6 inhibition in mouse models of Pseudomonas aeruginosa infection: A new glimpse for reducing inflammation and infection in cystic fibrosis
M Brindisi, S Barone, A Rossi, E Cassese, N Del Gaudio, ÁJF Morel, ...
European Journal of Pharmacology 936, 175349, 2022
强制性开放获取政策： Government of Italy
Targeting Endocannabinoid Metabolism: an Arrow with Multiple Tips Against Multiple Sclerosis
S Maramai, M Brindisi
ChemMedChem 15 (21), 1985-2003, 2020
强制性开放获取政策： Department of Biotechnology, India, Government of Italy
A First-in-Class Pyrazole-isoxazole Enhanced Antifungal Activity of Voriconazole: Synergy Studies in an Azole-Resistant Candida albicans Strain, Computational Investigation …
S Pelliccia, P Russomanno, S Barone, B Mateu, AI Alfano, M Miranda, ...
Journal of Medicinal Chemistry 67 (16), 14256-14276, 2024
强制性开放获取政策： European Commission
出版信息和资助信息由计算机程序自动确定